262 related articles for article (PubMed ID: 22438235)
1. Café-au-lait macules and intertriginous freckling in piebaldism: clinical overlap with neurofibromatosis type 1 and Legius syndrome.
Stevens CA; Chiang PW; Messiaen LM
Am J Med Genet A; 2012 May; 158A(5):1195-9. PubMed ID: 22438235
[TBL] [Abstract][Full Text] [Related]
2. Association of Piebaldism, multiple café-au-lait macules, and intertriginous freckling: clinical evidence of a common pathway between KIT and sprouty-related, ena/vasodilator-stimulated phosphoprotein homology-1 domain containing protein 1 (SPRED1).
Chiu YE; Dugan S; Basel D; Siegel DH
Pediatr Dermatol; 2013; 30(3):379-82. PubMed ID: 23016555
[TBL] [Abstract][Full Text] [Related]
3. Piebaldism Associated with Café-au-lait Macules and Intertriginous Freckling: A Case Report and Review of the Literature.
Akarsu S; İlknur T; Avcı C; Fetil E
Ann Dermatol; 2019 Oct; 31(5):567-570. PubMed ID: 33911651
[TBL] [Abstract][Full Text] [Related]
4. A novel missense KIT mutation causing piebaldism in one Chinese family associated with café-au-lait macules and intertriginous freckling.
Jia WX; Xiao XM; Wu JB; Ma YP; Ge YP; Li Q; Mao QX; Li CR
Ther Clin Risk Manag; 2015; 11():635-8. PubMed ID: 25960657
[TBL] [Abstract][Full Text] [Related]
5. Piebaldism with café-au-lait macules resulting from a novel mutation of KIT gene in a three-generation Chinese family.
Li X; Xing X; Liang X; Song C; Yang J; Ren D; Zhou Y
Skin Res Technol; 2023 Jun; 29(6):e13352. PubMed ID: 37357653
[TBL] [Abstract][Full Text] [Related]
6. Clinical and mutational spectrum of neurofibromatosis type 1-like syndrome.
Messiaen L; Yao S; Brems H; Callens T; Sathienkijkanchai A; Denayer E; Spencer E; Arn P; Babovic-Vuksanovic D; Bay C; Bobele G; Cohen BH; Escobar L; Eunpu D; Grebe T; Greenstein R; Hachen R; Irons M; Kronn D; Lemire E; Leppig K; Lim C; McDonald M; Narayanan V; Pearn A; Pedersen R; Powell B; Shapiro LR; Skidmore D; Tegay D; Thiese H; Zackai EH; Vijzelaar R; Taniguchi K; Ayada T; Okamoto F; Yoshimura A; Parret A; Korf B; Legius E
JAMA; 2009 Nov; 302(19):2111-8. PubMed ID: 19920235
[TBL] [Abstract][Full Text] [Related]
7.
Hegde SS; Srinivas SM; Nanjundappa N
Indian Dermatol Online J; 2023; 14(2):240-244. PubMed ID: 37089832
[TBL] [Abstract][Full Text] [Related]
8. [MULTIPLE CAFÉ-AU-LAIT MACULES AND INTERTRIGINOUS FRECKLING: BEYOND THE RASOPATHIES].
Eskin-Schwartz M; Mashkit E; Birk OS
Harefuah; 2023 Jun; 162(6):362-365. PubMed ID: 37394438
[TBL] [Abstract][Full Text] [Related]
9. Association of Piebaldism with Café-au-Lait Macules.
Kansal NK; Agarwal S
Skinmed; 2017; 15(3):223-225. PubMed ID: 28705289
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive RNA Analysis of the NF1 Gene in Classically Affected NF1 Affected Individuals Meeting NIH Criteria has High Sensitivity and Mutation Negative Testing is Reassuring in Isolated Cases With Pigmentary Features Only.
Evans DG; Bowers N; Burkitt-Wright E; Miles E; Garg S; Scott-Kitching V; Penman-Splitt M; Dobbie A; Howard E; Ealing J; Vassalo G; Wallace AJ; Newman W; ; Huson SM
EBioMedicine; 2016 May; 7():212-20. PubMed ID: 27322474
[TBL] [Abstract][Full Text] [Related]
11. Family with Legius syndrome (neurofibromatosis type 1-like syndrome).
Sakai N; Maeda T; Kawakami H; Uchiyama M; Harada K; Tsuboi R; Mitsuhashi Y
J Dermatol; 2015 Jul; 42(7):703-5. PubMed ID: 25981987
[TBL] [Abstract][Full Text] [Related]
12. Café-au-lait Macules and Neurofibromatosis Type 1: A Review of the Literature.
Bernier A; Larbrisseau A; Perreault S
Pediatr Neurol; 2016 Jul; 60():24-29.e1. PubMed ID: 27212418
[TBL] [Abstract][Full Text] [Related]
13. Letter: Misdiagnosis of "neurofibromatosis" in patients with piebaldism.
Spritz R
Dermatol Online J; 2011 Nov; 17(11):13. PubMed ID: 22136869
[TBL] [Abstract][Full Text] [Related]
14. Association of piebaldism and neurofibromatosis type 1 in a girl.
Angelo C; Cianchini G; Grosso MG; Zambruno G; Cavalieri R; Paradisi M
Pediatr Dermatol; 2001; 18(6):490-3. PubMed ID: 11841634
[TBL] [Abstract][Full Text] [Related]
15. Café-au-lait spots in neurofibromatosis type 1 and in healthy control individuals: hyperpigmentation of a different kind?
De Schepper S; Boucneau J; Vander Haeghen Y; Messiaen L; Naeyaert JM; Lambert J
Arch Dermatol Res; 2006 Apr; 297(10):439-49. PubMed ID: 16479403
[TBL] [Abstract][Full Text] [Related]
16. Interaction between a Domain of the Negative Regulator of the Ras-ERK Pathway, SPRED1 Protein, and the GTPase-activating Protein-related Domain of Neurofibromin Is Implicated in Legius Syndrome and Neurofibromatosis Type 1.
Hirata Y; Brems H; Suzuki M; Kanamori M; Okada M; Morita R; Llano-Rivas I; Ose T; Messiaen L; Legius E; Yoshimura A
J Biol Chem; 2016 Feb; 291(7):3124-34. PubMed ID: 26635368
[TBL] [Abstract][Full Text] [Related]
17. Legius syndrome, an Update. Molecular pathology of mutations in SPRED1.
Brems H; Legius E
Keio J Med; 2013; 62(4):107-12. PubMed ID: 24334617
[TBL] [Abstract][Full Text] [Related]
18. Legius Syndrome and its Relationship with Neurofibromatosis Type 1.
Denayer E; Legius E
Acta Derm Venereol; 2020 Mar; 100(7):adv00093. PubMed ID: 32147744
[TBL] [Abstract][Full Text] [Related]
19. Jaffe-Campanacci syndrome, revisited: detailed clinical and molecular analyses determine whether patients have neurofibromatosis type 1, coincidental manifestations, or a distinct disorder.
Stewart DR; Brems H; Gomes AG; Ruppert SL; Callens T; Williams J; Claes K; Bober MB; Hachen R; Kaban LB; Li H; Lin A; McDonald M; Melancon S; Ortenberg J; Radtke HB; Samson I; Saul RA; Shen J; Siqveland E; Toler TL; van Maarle M; Wallace M; Williams M; Legius E; Messiaen L
Genet Med; 2014 Jun; 16(6):448-59. PubMed ID: 24232412
[TBL] [Abstract][Full Text] [Related]
20. Predicting neurofibromatosis type 1 risk among children with isolated café-au-lait macules.
Ben-Shachar S; Dubov T; Toledano-Alhadef H; Mashiah J; Sprecher E; Constantini S; Leshno M; Messiaen LM
J Am Acad Dermatol; 2017 Jun; 76(6):1077-1083.e3. PubMed ID: 28318682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
